Endogenous SNP-Based Cell Line Identification in Mixed Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell line screening methods for drug development are laborious and costly, especially when dealing with multiple drug candidates and cell lines, as they require extensive barcoding and analysis, which can alter cell properties and is time-consuming.
Innovation Solution
The use of endogenous single nucleotide polymorphisms (SNPs) to identify and differentiate cell lines in a mixture without exogenous barcoding, allowing for the estimation of each cell line's proportion and the quantification of drug efficacy through deconvolution algorithms and next-generation sequencing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If exogenous barcode labeling is used to identify cell lines in mixtures, then cell line identification accuracy is improved, but the time and complexity of the screening process increases significantly
Solution Approach 1:
The invention extracts the identification markers (SNPs) from external barcodes and uses naturally occurring genetic variations already present in the cell lines. This eliminates the need for time-consuming barcode insertion and stable cell line selection, while still enabling accurate cell line identification through SNP-based deconvolution algorithms.
Solution Approach 2:
The cell lines' own genetic characteristics (endogenous SNPs) are utilized for identification purposes. Each cell line's unique SNP profile serves as its natural identifier, eliminating the need for external labeling systems and reducing the overall screening process time while maintaining identification accuracy.
2Adaptability or versatility
If exogenous barcode insertion is performed to enable mixed cell line screening, then cell line differentiation capability is improved, but the complexity of the manufacturing process increases
Solution Approach 1:
The invention removes the need for complex barcode insertion procedures by extracting and utilizing the naturally occurring SNP variations that already exist in different cell lines. This simplifies the manufacturing process while preserving the ability to differentiate between cell lines through SNP-based identification.
Solution Approach 2:
The SNP-based identification system serves multiple functions: it differentiates cell lines, tracks their proportions in mixtures, and enables drug response analysis all without requiring separate barcode insertion steps. This universal approach simplifies the overall process compared to exogenous barcoding systems.
3Productivity
If engineered cell lines with barcodes are used for screening, then mixed cell line screening efficiency is improved, but the reliability of screening results decreases due to potential alterations in cell properties
Solution Approach 1:
The invention uses the cell lines' inherent genetic characteristics (endogenous SNPs) for identification and tracking, rather than introducing external barcodes that could alter cell behavior. This self-service approach maintains cell line integrity and reliability while still enabling efficient mixed cell line screening through SNP-based deconvolution.
Solution Approach 2:
The invention changes the identification parameter from exogenous barcodes to endogenous SNPs. This parameter change allows for efficient mixed cell line screening while preserving cell line properties, as the SNPs are naturally occurring and do not require genetic engineering or external labeling that could affect cell behavior.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces the time and cost associated with cell line screening by accurately determining drug efficacy across multiple cell lines without altering their properties, providing a more efficient and precise method for drug development.
Implementation Method 1
identifying allele frequencies of SNPs in the treated mixture and a control mixture including cells from the same cell lines as present in the treated mixture
Data Source
AI summary
Methods for screening a test compound against multiple cell lines are provided and include the steps of: treating a mixture including cells from multiple cell lines with the test compound; identifying allele frequencies of single nucleotide polymorphisms (SNPs) in the treated mixture and a control mixture including cells from the same cell lines as present in the treated mixture; estimating a proportion of each individual cell line in both the treated mixture and the control mixture; and quantifying the effect of the test compound on each individual cell line using the estimated proportion of each cell line in the treated mixture and the estimated proportion of each cell line in the control mixture. Systems for screening a test compound against multiple cell lines, as well as systems and methods for identifying a proportion of a particular cell line in a mixture including multiple cell lines, are also provided.